Home » Prices » NASDAQ:NVAX

Novavax, Inc. stock price

Today's NASDAQ:NVAX chart, history & news

Price:
129.16 USD
Change:
+3.68 (2.93%)
Key Stats
Price open 124.98
Previous close 125.48
Market cap 8.22B
Volume 3.23M
Day high 132
Day low 124.62
Year high 178.51
Year low 3.93
Year to date change 3,055.70%
P/E Ratio -22.82
Company Profile
Fundamentals
Insider Information
News

About Novavax, Inc.

Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it has an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine for prevention of COVID-19. In June 2013, Novavax acquired the Matrix-M adjuvant platform with the purchase of Swedish company Isconova AB and renamed its new subsidiary Novavax AB.

Company information

Company name
Novavax, Inc.
Exchange
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Employees
375
CEO
Stanley Erck
Address
21 Firstfield Rd, Gaithersburg, Maryland, 20878-1757
Country
United States
Contact information
12402682000
Website
http://www.novavax.com/

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.